How about Guilin pharmaceutical co., ltd?

Brief introduction: Guilin Pharmaceutical Co., Ltd. was established in 1908 after the restructuring of the original Guilin Pharmaceutical Factory. After nearly a hundred years of development, it has become the largest chemical pharmaceutical enterprise with the most complete dosage forms in Guangxi and a national second-class enterprise. It has more than 200 kinds of chemical synthetic raw materials and preparations in several series, such as antiparasitic, vitamin, cardiovascular, antipyretic and analgesic. Artesunate, the core product, is a national patented new drug. It is the only effective derivative of artemisinin that can be made into water-soluble preparations at present, and is recommended as a high-quality antimalarial drug by the World Health Organization. The main products bumetanide, levamisole hydrochloride and levamisole phosphate have passed FDA certification. Guilin pharmaceutical products have entered the international market, registered and sold in more than 50 countries and regions in the world, accounting for 40% of its own industrial output value. On June+10, 2004, the company increased its registered capital from RMB 30 million to RMB 75 million. Among them, Fosun Industrial (600 196) contributed 26120,000 yuan (150,000 yuan is the subscribed registered capital, and1/20,000 yuan is included in Guilin Pharmaceutical Capital Provident Fund), accounting for 20% of the equity of Guilin Pharmaceutical; Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. invested 52.24 million yuan (30 million yuan as registered capital and 22.24 million yuan included in Guilin Pharmaceutical Capital Provident Fund), accounting for 40% of the shares of Guilin Pharmaceutical.

Legal Representative: Yu Zhemin

Established:1989-12-11.

Registered capital: 75 million yuan.

Industrial and commercial registration number: 45030000020893

Type of enterprise: other limited liability companies

Company address: No.0/7, Shanghai Road, Guilin.